Interleukin-2 dose, blood monocyte and CD25+ lymphocyte counts as predictors of clinical response to interleukin-2 therapy in patients with renal cell carcinoma
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning
Cellebiologi
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Cancer Immunol. Immunother. |
| Udgave nummer | 34 |
| Sider (fra-til) | 111-114 |
| Status | Udgivet - 1991 |
ID: 304584